BMI gain and insulin resistance among school-aged children: a population-based longitudinal study in the Brazilian

Barbara H Lourenço1, Suely G A Gimeno2, Marly A Cardoso3

  • 1Public Health Nutrition Program, School of Public Health, University of São Paulo,São Paulo,Brazil.

Insights

Childhood weight gain in the Amazon is linked to increased insulin resistance. Monitoring Body Mass Index (BMI) is crucial for preventing metabolic issues in school-aged children.

Area of Science:

  • Pediatrics
  • Metabolic Health
  • Public Health in Developing Countries

Background:

  • Non-communicable diseases (NCDs) pose a growing threat in developing nations, yet childhood metabolic determinants remain understudied.
  • Childhood obesity and its metabolic consequences are significant public health concerns, particularly in diverse populations like the Brazilian Amazon.

Purpose of the Study:

  • To investigate the association between weight gain (BMI-for-age Z-scores) and metabolic parameters in Amazonian school-aged children.
  • To assess the impact of increasing Body Mass Index (BMI) on glucose, insulin, insulin resistance (HOMA-IR), and blood pressure over a 2-year period.

Main Methods:

  • A population-based prospective study involving 696 children aged 4-10 years in the Brazilian Amazon.
  • Anthropometric measurements (BMI-for-age Z-scores) and metabolic markers (glucose, insulin, HOMA-IR, blood pressure) were collected at baseline and after a median 2-year follow-up.
  • Linear regression models were used to analyze the relationship between BMI changes and metabolic outcomes, adjusting for relevant covariates.

Main Results:

  • A significant increase in the prevalence of overweight children (BMI-for-age Z-score >1) was observed, rising from 10.1% to 15.8% (P=0.003).
  • Each unit increase in BMI-for-age Z-score was associated with a significant rise in fasting plasma insulin concentrations (+8.58 pmol/l) and HOMA-IR values (+1.47).
  • No significant associations were found between weight gain and changes in glucose concentrations or blood pressure levels.

Conclusions:

  • Increased BMI during childhood in the Brazilian Amazon is associated with elevated insulin resistance.
  • The rising prevalence of overweight children necessitates targeted interventions and monitoring of BMI trends to mitigate future metabolic disease risks.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
430
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
7
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
6